Follow
Enrico Longato
Enrico Longato
Department of Information Engineering, University of Padova
Verified email at dei.unipd.it
Title
Cited by
Cited by
Year
Prevalence and impact of diabetes among people infected with SARS-CoV-2
GP Fadini, ML Morieri, E Longato, A Avogaro
Journal of endocrinological investigation 43, 867-869, 2020
6272020
A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models
E Longato, M Vettoretti, B Di Camillo
Journal of biomedical informatics 108, 103496, 2020
1252020
Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID‐19 among people with type 2 diabetes: a case‐control study
GP Fadini, ML Morieri, E Longato, BM Bonora, S Pinelli, E Selmin, ...
Diabetes, Obesity and Metabolism 22 (10), 1946-1950, 2020
1082020
Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life
E Longato, B Di Camillo, G Sparacino, L Gubian, A Avogaro, GP Fadini
BMJ Open Diabetes Research and Care 8 (1), e001451, 2020
662020
Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy)
E Longato, B Di Camillo, G Sparacino, C Saccavini, A Avogaro, GP Fadini
Nutrition, Metabolism and Cardiovascular Diseases 30 (1), 84-91, 2020
522020
A deep learning approach to predict diabetes’ cardiovascular complications from administrative claims
E Longato, GP Fadini, G Sparacino, A Avogaro, L Tramontan, ...
ieee journal of biomedical and health informatics 25 (9), 3608-3617, 2021
352021
Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice
E Longato, B Di Camillo, G Sparacino, L Tramontan, A Avogaro, ...
Cardiovascular diabetology 19, 1-12, 2020
302020
Simple linear support vector machine classifier can distinguish impaired glucose tolerance versus type 2 diabetes using a reduced set of CGM-based glycemic variability indices
E Longato, G Acciaroli, A Facchinetti, A Maran, G Sparacino
Journal of diabetes science and technology 14 (2), 297-302, 2020
182020
Overview of iDPP@ CLEF 2022: the intelligent disease progression prediction challenge
A Guazzo, I Trescato, E Longato, E Hazizaj, D Dosso, G Faggioli, ...
CEUR WORKSHOP PROCEEDINGS 3180, 1130-1210, 2022
172022
Glycaemic variability-based classification of impaired glucose tolerance vs. type 2 diabetes using continuous glucose monitoring data
E Longato, G Acciaroli, A Facchinetti, L Hakaste, T Tuomi, A Maran, ...
Computers in biology and medicine 96, 141-146, 2018
172018
Overview of iDPP@ CLEF 2023: the intelligent disease progression prediction challenge
G Faggioli, A Guazzo, S Marchesin, L Menotti, I Trescato, A Helena, ...
CEUR WORKSHOP PROCEEDINGS 3497, 1123-1164, 2023
152023
Cardiovascular effectiveness of human-based vs. exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetes
E Longato, B Di Camillo, G Sparacino, L Tramontan, A Avogaro, ...
European journal of preventive cardiology 28 (1), 22-29, 2021
142021
Exposure to dipeptidyl‐peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: retrospective cohort study and meta‐analysis
ML Morieri, BM Bonora, E Longato, B Di Camilo, G Sparacino, ...
Diabetes, Obesity and Metabolism 22 (10), 1925-1934, 2020
132020
HAPT2D: high accuracy of prediction of T2D with a model combining basic and advanced data depending on availability
B Di Camillo, L Hakaste, F Sambo, R Gabriel, J Kravic, B Isomaa, ...
European journal of endocrinology 178 (4), 331-341, 2018
132018
Expected accuracy of proximal and distal temperature estimated by wireless sensors, in relation to their number and position on the skin
E Longato, M Garrido, D Saccardo, C Montesinos Guevara, AR Mani, ...
PloS one 12 (6), e0180315, 2017
122017
Intelligent disease progression prediction: overview of iDPP@ CLEF 2022
A Guazzo, I Trescato, E Longato, E Hazizaj, D Dosso, G Faggioli, ...
International Conference of the Cross-Language Evaluation Forum for European …, 2022
102022
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study
ML Morieri, E Longato, M Mazzucato, B Di Camillo, A Cocchiglia, ...
Cardiovascular Diabetology 18, 1-9, 2019
102019
Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study
E Longato, B Di Camillo, G Sparacino, L Tramontan, A Avogaro, ...
Cardiovascular Diabetology 20, 1-12, 2021
72021
Outcomes of patients with type 2 diabetes treated with SGLT-2 inhibitors versus DPP-4 inhibitors. An Italian real-world study in the context of other observational studies
E Longato, BM Bonora, B Di Camillo, G Sparacino, L Tramontan, ...
Diabetes Research and Clinical Practice 179, 109024, 2021
72021
Prediction of cardiovascular complications in diabetes from pharmacy administrative claims
E Longato, GP Fadini, G Sparacino, L Gubian, B Di Camillo
2020 IEEE 20th Mediterranean Electrotechnical Conference (MELECON), 315-320, 2020
72020
The system can't perform the operation now. Try again later.
Articles 1–20